Trial Profile
Sabril for Treatment of Adult Refractory Partial Seizures Symptomatic of Tuberous Sclerosis: An Open Label, Phase IV Prospective Safety and Tolerability Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Vigabatrin (Primary)
- Indications Complex partial epilepsy
- Focus Adverse reactions
- Acronyms STARS: TS
- 01 Dec 2016 Status changed from recruiting to discontinued.
- 31 Dec 2010 New trial record